LoginRegister

    Suven gets product patents from Aripo and South Korea

    Written by Ruby Khatun Khatun   |  
    Suven gets product patents from Aripo and South Korea

    New Delhi: Suven Life Sciences has secured a product patent each from African Regional Intellectual Property Organisation (Aripo) and South Korea corresponding to new chemical entities (NCEs) for the treatment of disorders associated with neurodegenerative diseases.


    The two patents are valid through 2033 and 2034, respectively, the company said in a BSE filing.



    "We are pleased by the grant of these patents to Suven for our pipeline of molecules in the central nervous system (CNS) arena, which is being developed for cognitive disorders with high unmet medical need with a huge market potential globally," Suven Life CEO Venkat Jasti said.





    According to the company, the granted claims of the patents are being developed as therapeutic agents and are useful in the treatment of cognitive impairment associated with neurodegenerative disorders like Alzheimer's disease, Parkinson, and Schizophrenia.



    African Regional Intellectual Property OrganisationAlzheimer's diseaseAripoCentral Nervous Systemneurodegenerative diseasesNew Chemical EntitiesParkinsonpatentproduct patentsschizophreniaSouth KoreaSuvenSuven LifeSuven Life SciencesVenkat Jasti
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X